Status:
COMPLETED
Corneal Endothelial Cell Changes After Phacoemulsification in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Beijing Tsinghua Chang Gung Hospital
Conditions:
Cataract
Diabetes Mellitus
Eligibility:
All Genders
58-86 years
Brief Summary
This study investigate the change of the corneal endothelial cells in patients with type 2 diabetes after phacoemulsification with intraocular lens implantation.
Detailed Description
The investigators do the clinical prospective study including 30 patients with type 2 diabetes and 30 control patients without diabetes scheduled to undergo cataract surgery. The corneal endothelial c...
Eligibility Criteria
Inclusion
- the experimental group:
- Clinical diagnosis of cataract
- Type 2 diabetes mellitus
- The recent blood glucose control was stable
- The glycosylated hemoglobin \< 8%
- The control group:
- Clinical diagnosis of cataract
- No history of type 2 diabetes
Exclusion
- Corneal lesions
- Anterior inflammation
- Ocular trauma or surgical history
- Glaucoma
- Corneal endothelial cell density \< 1500 / mm squared
Key Trial Info
Start Date :
September 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03260673
Start Date
September 1 2015
End Date
July 30 2016
Last Update
August 24 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.